Contact
The magazine of the Federation of Spanish Diabetics, DiabetesFEDE, publishes an interview with Joan Guinovart on the latest developments in the field of cell metabolism, in particular glycogen, in which the group at IRB specializes. Guinovart emphasizes that the knowledge generated in the coming years will produce revolutionary changes in the field of biomedicine.
Read the interview in the magazine of the Spanish Diabetes Federation (PDF in Spanish)
Related news
27 February 2014
Researchers reveal the dual role of brain glycogen
2 May 2012
Glycogen accumulation in neurons causes brain damage and shortens the lives of flies and mice
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
